Changes in subcellular distribution and phosphorylation of GluR1 in lesioned striatum of 6-hydroxydopamine-lesioned and l-dopa-treated rats.
about
Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.Exercise modifies α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor expression in striatopallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse.Interactions of CaMKII with dopamine D2 receptors: roles in levodopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson's ratsCa2+/calmodulin-dependent protein kinase II inhibitors disrupt AKAP79-dependent PKC signaling to GluA1 AMPA receptors.Post-translational modification biology of glutamate receptors and drug addictionPostsynaptic density protein 95-regulated NR2B tyrosine phosphorylation and interactions of Fyn with NR2B in levodopa-induced dyskinesia rat modelsNMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and β-arrestin-1 expression in parkinsonian rats.Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's disease.Therapeutic potential of targeting glutamate receptors in Parkinson's disease.Early synaptic dysfunction in Parkinson's disease: Insights from animal models.l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?Human aging in the post-GWAS era: further insights reveal potential regulatory variants.Comparison of immunoreactivities of calbindin-D28k, calretinin and parvalbumin in the striatum between young, adult and aged mice, rats and gerbils.Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson's disease.Reduced calcium/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP-treated mice.
P2860
Q33573371-0CE8BA00-9FE7-4538-BDBB-6C6BC37DEEC1Q34362073-A5F9F397-DA6B-4FFB-A856-A558E9B118D2Q34417485-01EAFE03-E13D-4326-83B7-2DACBE1C0B73Q34675786-0AFE57D9-19E0-4773-BB6F-530A43342DC6Q34706306-C75D866A-5122-40AE-B24A-ADF2488285FAQ34783370-342FB8B7-06B1-4B5C-BD88-810EB7953105Q36738475-2F3001CF-0BB8-421C-83CE-FABAF4049A88Q38056852-98965C60-8CA1-440B-9945-90FF0DE949E8Q38190016-92F9DD1A-CACF-4141-B994-CE1DA11F3D27Q38837604-13DC2375-BED4-47F0-A68A-9F558D44C924Q39012371-7D58A5E1-5D2A-418C-8435-758AC3F9C45FQ39015956-2E2615C1-EDCA-4D3D-AE01-FD95098C5ED5Q41443944-7AA87A99-CD18-4C60-8E9F-E051E3C3E1FDQ43067885-C88F3BF2-4679-4C12-A787-542016222212Q51839227-89FADA52-C50C-4A1D-AFE2-E27A9B3980E0
P2860
Changes in subcellular distribution and phosphorylation of GluR1 in lesioned striatum of 6-hydroxydopamine-lesioned and l-dopa-treated rats.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Changes in subcellular distrib ...... ioned and l-dopa-treated rats.
@en
Changes in subcellular distrib ...... ioned and l-dopa-treated rats.
@nl
type
label
Changes in subcellular distrib ...... ioned and l-dopa-treated rats.
@en
Changes in subcellular distrib ...... ioned and l-dopa-treated rats.
@nl
prefLabel
Changes in subcellular distrib ...... ioned and l-dopa-treated rats.
@en
Changes in subcellular distrib ...... ioned and l-dopa-treated rats.
@nl
P2093
P1476
Changes in subcellular distrib ...... ioned and l-dopa-treated rats.
@en
P2093
Guoqiang Lu
Guozhao Ma
Hongqi Yang
Shengdi Chen
Zhenguo Liu
P2888
P304
P356
10.1007/S11064-006-9177-9
P577
2006-10-20T00:00:00Z